Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient
Open Access
- 19 January 2015
- journal article
- Published by SAGE Publications in Journal of the Intensive Care Society
- Vol. 16 (2), 147-153
- https://doi.org/10.1177/1751143714564816
Abstract
The treatment of sepsis remains a significant challenge and is the cause of high mortality and morbidity. The pathophysiological alterations that are associated with sepsis can complicate drug dosing. Critical care patients often have capillary leak, increased cardiac output and altered protein levels which can have profound effects on the volume of distribution (Vd) and clearance (Cl) of antibacterial agents, both of which may affect the pharmacokinetics (PK) / pharmacodynamics (PD) of the drug. Along with antibacterial factors such as the hydrophilicity and its kill characteristics and the susceptibility and site of action of the microorganism, different dosing and administration strategies may be needed for the different drug classes. In conclusion, developing dosing and administration regimes of antibacterials that adhere to PK/PD principles increase antibacterial exposure. Tailoring therapy to the individual patient combined with TDM may contribute to improved clinical efficacy and contain the spread of resistance.Keywords
This publication has 28 references indexed in Scilit:
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Clinical Infectious Diseases, 2014
- Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokineticsJournal of Antimicrobial Chemotherapy, 2010
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusionInternational Journal of Antimicrobial Agents, 2009
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infectionsInternational Journal of Antimicrobial Agents, 2008
- Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: A retrospective, nonrandomized, open-label, historical chart reviewClinical Therapeutics, 2007
- Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentrationJournal of Antimicrobial Chemotherapy, 2006
- Effects of renal failure on drug transport and metabolismPharmacology & Therapeutics, 2006
- Therapeutic Intervention and Targets for SepsisAnnual Review of Medicine, 2005